首页 >
法规速递
-
Page: Aprepitant product-specific bioequivalence guidance-2025/7/30
2025-07-31查看详情 > -
Page: Vortioxetine hydrobromide / vortioxetine lactate product-specific bioequivalence guidance-2025/7/30
2025-07-31查看详情 > -
Page: Zonisamide product-specific bioequivalence guidance-2025/7/30
2025-07-31查看详情 > -
Document: List of medicinal products under additional monitoring-2025/7/30
2025-07-31查看详情 > -
Document: List of medicinal products under additional monitoring-2025/7/30
2025-07-31查看详情 > -
Document: List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)-2025/7/30
2025-07-31查看详情 > -
Page: Paclitaxel product-specific bioequivalence guidance-2025/7/30
2025-07-31查看详情 > -
Page: Emtricitabine/tenofovir disoproxil product-specific bioequivalence guidance-2025/7/30
2025-07-31查看详情 > -
Page: Colchicine product-specific bioequivalence guidance-2025/7/30
2025-07-31查看详情 > -
Page: Ticagrelor product-specific bioequivalence guidance-2025/7/30
2025-07-31查看详情 >
